Skip to main content

NHGRI Commits $9.5M for '$1000 Genome' Technology in FY 2010

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has issue three funding announcements that outline its plans for supporting the development of low-cost sequencing tools in the 2010 fiscal year.

The three grants under the "Revolutionary Genome Sequencing Technologies — The $1,000 Genome" program will award a total of $9.5 million in 2010 to develop tools that can help lower the cost of sequencing a full mammalian-sized genome. These studies could involve full-scale sequencing systems or components of the underlying genome sequencing systems, NHGRI said.

Through an R01 grant mechanism, NHGRI will fund between two and seven awards totaling up to $5 million in 2010 and again in 2011. Applicants for the program may seek funding for up to four years and for direct costs of up to $1.5 million per year.

An R21 program will award $2 million in 2010 and again in 2011 to between two and seven grants.

A third grant program, through the Small Business Innovation Research mechanism, will grant up to $2.5 million in 2010 to between two and five projects, while future funding amounts may vary.

Under the SBIR program, Phase I grants will receive up to $250,000 in total costs per year for up to two years and Phase II grants will receive up to $1.5 million for as many as three years, NHGRI said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.